Plastics, Pills and Painkillers: Effects of In-utero Exposures on Male Reproductive Health
Donate
At the International IVF Initiative, we are committed to providing free access to our educational sessions, webinars, and resources for professionals and individuals passionate about advancing reproductive medicine. We believe that cost should never be a barrier to knowledge and collaboration. By contributing, you’re ensuring that valuable educational resources, expert insights, and collaborative opportunities remain open to all without financial barriers. Together, we can continue to foster a global community dedicated to innovation and excellence in the field of IVF.
Your Donation
Thank you!
Plastics, Pills and Painkillers: Effects of In-utero Exposures on Male Reproductive Health
Tuesday 7th September, 2021. 3PM EST/ 8PM GMT / 9PM CET
PROF. ROD MITCHELL
His research interests are focused on the role of the germ-stem cell niche on germ cell development in the fetal and prepubertal testis. This includes investigating the effect of exposure to proposed environmental ‘endocrine disrupting chemicals’ (EDC’s) on human fetal testis development. Exposure to several such agents have been postulated to increase the risk of developing male reproductive disorders including infertility and testicular cancer.
His group have shown the impact of several proposed ‘EDC’s’, including analgesics commonly used during pregnancy, on the development of the human fetal testis in terms of testosterone production and germ cell development. These studies include the use of a xenograft approach developed in his laboratory. Importantly, these studies have highlighted some important differences between rodent and human in terms of the effect of such exposures on the testis. In addition to his interests in EDC’s he also has a clinical and research interest in fertility preservation for young males treated for cancer. Edinburgh recently became the first UK Centre to develop a fertility preservation programme to store testicular tissue from young boys with cancer prior to their treatment, as part of the 'Edinburgh Fertility Preservation’ programme, for which Rod is the lead for male fertility preservation.